MedPath

Effect of Mayaphala Granules on Diabetes

Phase 1
Conditions
Health Condition 1: null- Patients with type-2 Diabetes mallitus
Registration Number
CTRI/2014/04/004562
Lead Sponsor
Institute for Post Graduate Teaching and Research in Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Patients who have Fasting Blood Sugar equal or more than 126mg per dl and Post Prandial either 200 or more than 200 mgf per dl will be included in this clinical study

Exclusion Criteria

Patients of age below 30 and after 70 yrs

Patients having Ischemic heart disease

AIDS

Cancer

Pregnancy

Severe hypertension

Thyrotoxicosis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The efficacy of treatment will be assessed on the <br/ ><br>basis of relief in signs and symptoms. <br/ ><br>Evaluation of biochemical parameters such as <br/ ><br>FBS, PPBS in both groups along with <br/ ><br>Hematological, Urine routine and microscopic <br/ ><br>examination before and after the treatment. S.Insulin before and after the treatment.(if possible )Timepoint: At interval of one month and of two months the <br/ ><br>Evaluation of biochemical parameters such as <br/ ><br>FBS, PPBS in both groups along with <br/ ><br>Hematological, Urine routine and microscopic <br/ ><br>examination before and after the treatment. S. <br/ ><br>Insulin before <br/ ><br>and after the treatment <br/ ><br>and the efficacy of treatment will be assessed <br/ ><br>on the basis of relief in signs and symptoms.
Secondary Outcome Measures
NameTimeMethod
Assessment of chief complaints like polyuria polydipsia and polyphagiaTimepoint: two months
© Copyright 2025. All Rights Reserved by MedPath